Hi, I'm Jo.
- Biomedicine & Nutrition Scientist
- Interested in Obesity, GLP-1/GIP Agonists, Nutrition, Exercise, Writing, & Software Dev.
- Do not miss any update of my work Follow me now.
GLP-1 agonists (such as Ozempic, Wegovy, and Rybelsus) and GLP1/GIP agonists (like Monjaro) are revolutionizing obesity treatment.
These medications effectively suppress hunger and reduce cravings for sugary and high-fat foods, making them a GAMECHANGER for those who have struggled to lose weight despite numerous attempts at dieting and exercise.
However, it's important to address some common fears and misinformation surrounding these treatments. For example, it is not recommended to take the medication and continue with old habits. Instead, use the opportunity provided by GLP-1 agonists to lose accumulated fat by adopting new diet and exercise routines. This will help build a foundation for maintaining a healthy weight in the long term.
On this site, I write with passion about the journey to overcoming obesity. My goal is to provide you with valuable information and insights that will support your path to a healthier, obesity-free life. Explore the content here to find guidance, tips, and encouragement tailored to help you finally achieve and maintain a healthy weight.